Skip to main content
Caplight Logo









BIO INX

BIO INX

Private
BelgiumHealthcare & Life Scienceshttps://bioinx.com/

Last Round

Grant

Jul 4, 2024

Total Funding Raised

$958,000

Company Overview

BIO INX is a biotechnology company that develops and commercializes materials and bio-inks for 3D bioprinting.

Sector

Healthcare & Life Sciences

Verticals

Advanced Materials, 3D Printing, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bio-inks3D bioprintingbioprinting materialstissue engineeringregenerative medicinebioprinting consumableslive cell printing3D printed tissueshigh-resolution bioprintingdrug screeningGel-MAtissue scaffoldsorgan printingbiodegradable resinsacrificial inkcosmetics screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIO INX Comparables

Compare BIO INX with similar companies based on industry and business-model similarity.

BIO INX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TissueLabs
87%
Axolotl Biosciences
86%
Foldink
85%

BIO INX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 4, 2024
SeedSep 16, 2022

Key People

Founding team and executive leadership

Jasper Van Hoorick

Chief Executive Officer

Executive Team

BIO INX Investors

Notable investors and investment history

BIO INX investors
InvestorRounds
Interreg CrossRoads ProgrammeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2025

    Monthly visitors grew 63% MoM, from 3K to 4.9K.

  • Feb 7, 2025

    Grew 50% QoQ, from 8 to 12 employees.

BIO INX Filings

Explore SEC and related filing metadata, where available.

BIO INX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BIO INX's valuation, stock price, and market status.

Is BIO INX a public or private company?

BIO INX is a private company.

What is the current stock price of BIO INX?

BIO INX is a private company with no public stock price. No recent secondary market data is available.

How much is BIO INX worth (valuation)?

Valuation information for BIO INX is not publicly available.

Can I buy BIO INX stock?

BIO INX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BIO INX's last funding round?

BIO INX's most recent funding round was Grant on July 4, 2024.

Who are the main investors in BIO INX?

Key investors in BIO INX include Interreg CrossRoads Programme.

Will BIO INX IPO soon?

No public IPO plans have been announced for BIO INX.

How can I track BIO INX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIO INX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range10
Year Founded2022
Last FundingJul 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?